SECONDARY ETIOLOGICAL FACTORS IN THE DEVELOPMENT OF PERI-IMPLANTITIS
Purpose: The aim of this review was to investigate the potential impact of secondary etiological factors on the development of peri-implant infections. Results: During the review process we found sufficient evidence to define the following factors as secondary etiological factors for the development...
保存先:
第一著者: | |
---|---|
フォーマット: | 図書 |
出版事項: |
Peytchinski Publishing,
2021-04-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_bf1a2dfb29484cd684dceb3af49b15b8 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Elitsa Sabeva |e author |
245 | 0 | 0 | |a SECONDARY ETIOLOGICAL FACTORS IN THE DEVELOPMENT OF PERI-IMPLANTITIS |
260 | |b Peytchinski Publishing, |c 2021-04-01T00:00:00Z. | ||
500 | |a 10.5272/jimab.2021272.3682 | ||
500 | |a 1312-773X | ||
520 | |a Purpose: The aim of this review was to investigate the potential impact of secondary etiological factors on the development of peri-implant infections. Results: During the review process we found sufficient evidence to define the following factors as secondary etiological factors for the development of peri-implantitis: a history of periodontitis; implant surface characteristics; suprastructure characteristics; cemented restorations; implant-abutment connection; smoking; diabetes and peri-implant mucosa characteristics. Conclusion: To reduce the risk of peri-implantitis, the following recommendations should be considered: (1) in partially edentulous patients, implant treatment should start after elimination of the periodontal infection and after the establishment of a stable periodontal status; (2) implants should be placed in areas where there is a minimum of 2 mm of keratinized mucosa; (3) an internal implant-abutment connection and screw-retained suprastructures are preferred; (4) suprastructures should be planned carefully to facilitate good oral hygiene; and (5) smoking cessation should be promoted and (6) only patients with controlled diabetes should undergo implant placement. | ||
546 | |a EN | ||
690 | |a peri-implantitis | ||
690 | |a peri-implant mucositis | ||
690 | |a peri-implant infection | ||
690 | |a Dentistry | ||
690 | |a RK1-715 | ||
690 | |a Medicine (General) | ||
690 | |a R5-920 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of IMAB, Vol 27, Iss 2, Pp 3682-3687 (2021) | |
787 | 0 | |n https://www.journal-imab-bg.org/issues-2021/issue2/2021vol27-issue2-3682-3687.pdf | |
787 | 0 | |n https://doaj.org/toc/1312-773X | |
856 | 4 | 1 | |u https://doaj.org/article/bf1a2dfb29484cd684dceb3af49b15b8 |z Connect to this object online. |